Related topic: Copaxone, Acute lymphocytic leukaemia
Review: could Copaxone cause Acute lymphocytic leukaemia?
Summary: Acute lymphocytic leukaemia could be caused by Copaxone, especially for people who are male, 30-39 old.
We study 10,134 people who have side effects while taking Copaxone from FDA and social media. Among them, 2 have Acute lymphocytic leukaemia. Find out below who they are, when they have Acute lymphocytic leukaemia and more.
How are my drugs for patients like me? On eHealthMe, you can research 300 million drug outcomes from FDA and social media. All studies are personalized to gender and age. Start now, it's anonymous, simple & free >>>
Copaxone (latest outcomes from 10,347 users) has active ingredients of glatiramer acetate. It is often used in multiple sclerosis.
Acute lymphocytic leukaemia
Acute lymphocytic leukaemia (cancer of the white blood cells) (latest reports from 10,464 patients) has been reported by people with acute lymphocytic leukemia (all), multiple myeloma, chronic myeloid leukaemia, high blood pressure, rheumatoid arthritis.
On Apr, 8, 2014: 10,140 people reported to have side effects when taking Copaxone. Among them, 2 people (0.02%) have Acute Lymphocytic Leukaemia. They amount to 0.02% of all the 10,600 people who have Acute Lymphocytic Leukaemia on eHealthMe.
Time on Copaxone when people have Acute lymphocytic leukaemia * :
Gender of people who have Acute lymphocytic leukaemia when taking Copaxone * :
|Acute lymphocytic leukaemia||0.00%||100.00% |
Age of people who have Acute lymphocytic leukaemia when taking Copaxone * :
|Acute lymphocytic leukaemia||0.00%||0.00%||0.00%||0.00%||100.00%||0.00%||0.00%||0.00% |
Severity of Acute lymphocytic leukaemia when taking Copaxone ** :
How people recovered from Acute lymphocytic leukaemia ** :
Top conditions involved for these people * :n/a
Top co-used drugs for these people * :n/a
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
You can also:
On eHealthMe, Copaxone (glatiramer acetate) is often used for multiple sclerosis. Find out below the conditions Copaxone is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Copaxone used for and how effective is it:
Other drugs that are used to treat the same conditions:
Could it be a symptom from a condition:
Drugs in real world that are associated with:
Could your condition cause it?
Comments from related studies:
From this study (2 months ago):
Immediate reaction to injection. 7x8" rash which turned into infection and two weeks later, having external stabbing and likely scarring of 2x3" size
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Copaxone, Acute lymphocytic leukaemia
More reviews for: Copaxone, Acute lymphocytic leukaemia
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.